Over the next 5 years, branded pharmaceutical manufacturers face a period of intense generic competition as numerous branded blockbusters face patent expiry. Consequently, having a clear idea about how to maximize portfolio sales and defend against generic competitors is one of the most critical considerations when considering lifecycle management (LCM) strategies.
Features and benefits
Developmental lifecycle management can boost revenues both in the mid and late stages of a drug’s lifecycle and are a preferred option so long as the likelihood of their success is high, depending on product characteristics and market environment.
Buy this report @ http://www.reportsnreports.com/reports/159811-generics-defense-strategies.html
Released On: 9/3/2012
Views: 3179
Released On: 8/31/2012
Views: 3906
Released On: 8/27/2012
Views: 2192
Released On: 8/23/2012
Views: 3046
Released On: 8/23/2012
Views: 2074
Released On: 8/21/2012
Views: 2770
Released On: 8/16/2012
Views: 3403
Released On: 8/16/2012
Views: 2021
Released On: 8/16/2012
Views: 4270
Released On: 8/14/2012
Views: 2155
Released On: 8/14/2012
Views: 1849